⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026
globenewswire.com
MYGN
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
globenewswire.com
MYGN
Myriad Genetics, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
MYGN
Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More
globenewswire.com
ILMN
QGEN
MDXH
MYGN
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
businesswire.com
REGN
AMGN
ABT
TMO
RVTY
MYGN
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
globenewswire.com
MYGN
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
prnewswire.com
TLX
MYGN
Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
prnewswire.com
SPGI
VRT
LITE
COHR
SATS
NSSC
ALEX
MU
LRCX
AMAT
GEV
PYPL
AIG
MET
TGT
MTCH
MOH
LW
PAYC
SOLS
SITM
MOG.A
IDCC
VICR
CTRE
GTM
ASGN
KMPR
VSEC
AGX
RITM
LYFT
LAUR
LTH
LIF
SPHR
PLAY
SXC
AHRT
INN
KREF
BLMN
MYGN
CARS
ANGI
University of Utah to expand innovation support across West in partnership with USPTO
prnewswire.com
MYGN
Myriad Commercially Launches Precise MRD with Select Community Oncologists
globenewswire.com
MYGN